<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<title>Yichang Zhao – Academic Homepage</title>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;600;700&display=swap" rel="stylesheet" />

<style>
  body {
    margin: 0;
    font-family: "Inter", sans-serif;
    background: #ffffff;
    color: #111;
    line-height: 1.7;
  }
  header {
    text-align: center;
    padding: 60px 20px 20px;
  }
  header img {
    width: 150px;
    border-radius: 8px;
  }
  header h1 {
    margin: 20px 0 10px;
    font-size: 2.4rem;
    font-weight: 700;
  }
  header p {
    font-size: 1.1rem;
    opacity: 0.8;
  }
  nav {
    text-align: center;
    padding: 15px 0;
    border-bottom: 1px solid #ddd;
    margin-bottom: 20px;
  }
  nav a {
    margin: 0 15px;
    font-size: 1rem;
    text-decoration: none;
    color: #003366;
    font-weight: 600;
  }
  .container {
    max-width: 900px;
    margin: 0 auto;
    padding: 10px 20px 40px;
  }
  h2 {
    margin-top: 40px;
    font-size: 1.6rem;
    font-weight: 700;
    border-bottom: 1px solid #ddd;
    padding-bottom: 6px;
  }
  details {
    margin-bottom: 18px;
  }
  summary {
    cursor: pointer;
    font-size: 1.1rem;
    font-weight: 600;
    padding: 6px 0;
  }
  .pub-entry {
    margin-bottom: 15px;
  }
  .footer {
    text-align: center;
    padding: 40px;
    font-size: 0.9rem;
    color: #666;
  }
  a { color: #003366; }
</style>
</head>

<body>

<nav>
  <a href="#about">About</a>
  <a href="#pubs">Publications</a>
  <a href="#cv">CV</a>
  <a href="#contact">Contact</a>
</nav>

<header>
  <img src="https://raw.githubusercontent.com/zhaoyichang123/zhaoyichang123.github.io/main/photo.png" alt="Profile Photo" />
  <h1>Yichang Zhao</h1>
  <p>Ph.D. Candidate · Clinical Pharmacy · The Second Xiangya Hospital of Central South University</p>
</header>

<div class="container">

<!-- ====================== ABOUT ========================= -->
<h2 id="about">About</h2>
<p>Email: <a href="mailto:zhaoyichang@csu.edu.cn">zhaoyichang@csu.edu.cn</a></p>
<p>ORCID: <a href="https://orcid.org/0000-0002-9651-4457">0000-0002-9651-4457</a></p>
<p>Google Scholar: <a href="https://scholar.google.com/citations?user=ZrNKcgIAAAAJ">Profile</a></p>

<p>
Research activities focus on antimicrobial pharmacology, infectious disease epidemiology,
and clinical pharmacokinetics. Current work emphasizes optimization of antimicrobial therapy,
characterization of PK/PD variability, and identification of clinical and environmental determinants
of antimicrobial resistance.
</p>

<p>
Quantitative methodologies—including meta-analysis, population pharmacokinetic (PopPK)
modeling, real-world data analytics, and causal inference—are applied to support individualized dosing
strategies and evidence-based antimicrobial stewardship.
</p>

<!-- ====================== EMPLOYMENT ========================= -->
<h2>Employment</h2>
<ul>
  <li><strong>The Second Xiangya Hospital of Central South University</strong>, Changsha, China (2017–2019)<br>
      Administrative Secretary, GCP Office & Medical Ethics Committee</li>
  <li><strong>First Affiliated Hospital of Hunan University of Medicine</strong>, Huaihua, China (2014–2015)<br>
      Clinical Pharmacist</li>
</ul>

<!-- ====================== EDUCATION ========================= -->
<h2>Education</h2>
<ul>
  <li><strong>Ph.D. in Clinical Pharmacy</strong> (2022–2026)<br>The Second Xiangya Hospital, Central South University</li>
  <li><strong>Master of Clinical Pharmacy</strong> (2019–2022)<br>The Second Xiangya Hospital, Central South University</li>
  <li><strong>Bachelor of Pharmacy</strong> (2010–2014)<br>Xiangya School of Medicine, Central South University</li>
</ul>

<!-- ====================== HONORS ========================= -->
<h2>Distinctions & Honors</h2>
<ul>
  <li>National Doctoral Scholarship – Ministry of Education (2022, 2024, 2025)</li>
  <li>Selected Young Scientist – 72nd Lindau Nobel Laureate Meeting</li>
  <li>Person of the Year – Central South University (2023)</li>
  <li>CSU Innovation Award · President’s Scholarship (2023)</li>
</ul>

<!-- ====================== FUNDING ========================= -->
<h2>Funding</h2>
<ul>
  <li><strong>NIHAYSZX2502</strong> – IoT/GIS-based CR-GNB early-warning system  
      <br>National Health Commission of China</li>
  <li><strong>202113012480</strong> – Voriconazole dosing in hepatic dysfunction  
      <br>Health Commission of Hunan Province</li>
</ul>

<!-- ====================== PUBLICATIONS ========================= -->
<h2 id="publications">Publications</h2>

<!-- ==================== 2025 ==================== -->
<details open>
  <summary>2025 — 7 publications</summary>

  <div class="pub-entry">
    Li J-K., <strong>Zhao Y-C.</strong>, Wu S-Q., Zhang Y-K., Liu J-Y., Fu R., Zhang B-K., Yan M.  
    <em>The pharmacy graduate global competence evaluation scale (PGGCES): a nationwide study in China.</em>  
    BMC Medical Education, 2025.  
    <a href="https://doi.org/10.1186/s12909-025-07859-4">DOI: 10.1186/s12909-025-07859-4</a>
  </div>

  <div class="pub-entry">
    <strong>Zhao Y-C.</strong>, Wu S-Q., Li J-K., Sun Z-H., Zhang B-K., Fu R., Yan M.  
    <em>Predictive value of the combined triglyceride-glucose and frailty index for cardiovascular disease and stroke in two prospective cohorts.</em>  
    Cardiovascular Diabetology, 2025.  
    <a href="https://doi.org/10.1186/s12933-025-02880-9">DOI: 10.1186/s12933-025-02880-9</a>
  </div>

  <div class="pub-entry">
    <strong>Zhao Y-C.</strong>, Sun Z-H., Li J-K., Liu H-Y., Xiao M-X., Zhang B-K., Cao W., Yan M.  
    <em>From gram-negative strains to mortality: understanding bacterial resistance in mainland China.</em>  
    Environmental Sciences Europe, 2025.  
    <a href="https://doi.org/10.1186/s12302-025-01111-y">DOI: 10.1186/s12302-025-01111-y</a>
  </div>

  <div class="pub-entry">
    <strong>Zhao Y-C.</strong>, Li J-K., Zhang Y-K., Sun Z-H., Fu R., Zhang B-K., Yan M.  
    <em>Evaluating the influence of MRSA co-infection on 28-day mortality among sepsis patients: insights from the MIMIC-IV database.</em>  
    Frontiers in Pharmacology, 2025.  
    <a href="https://doi.org/10.3389/fphar.2025.1534107">DOI: 10.3389/fphar.2025.1534107</a>
  </div>

  <div class="pub-entry">
    <strong>Zhao Y-C.</strong>, Zhang Y-K., Gao W., Liu H-Y., Xiao C-L., Hou J-J., Li J-K., Zhang B-K., Xiang D-X., Sandaradura I., Yan M.  
    <em>A preliminary exploration of liver microsomes and PBPK to uncover the impact of CYP3A4/5 and CYP2C19 on tacrolimus and voriconazole drug-drug interactions.</em>  
    Scientific Reports, 2025.  
    <a href="https://doi.org/10.1038/s41598-025-91356-7">DOI: 10.1038/s41598-025-91356-7</a>
  </div>

  <div class="pub-entry">
    <strong>Zhao Y-C.</strong>, Xiao M-X., Sun Z-H., Li J-K., Liu H-Y., Zhang B-K., Cai H-L., Cao W., Yu F., Yan M.  
    <em>Unmasking MRSA antibiotic resistance: the impact of environment, pollution, and healthcare quality—a nationwide exploration in China.</em>  
    Environmental Sciences Europe, 2025.  
    <a href="https://doi.org/10.1186/s12302-025-01064-2">DOI: 10.1186/s12302-025-01064-2</a>
  </div>

  <div class="pub-entry">
    Sun Z-H., <strong>Zhao Y-C.</strong>, Li J-K., Peng F., Yu F., Zhang B-K., Yan M.  
    <em>Population dynamics analysis of the interaction between tacrolimus and voriconazole in renal transplant recipients.</em>  
    Frontiers in Pharmacology, 2025.  
    <a href="https://doi.org/10.3389/fphar.2024.1502097">DOI: 10.3389/fphar.2024.1502097</a>
  </div>

</details>


<!-- ==================== 2024 ==================== -->
<details>
  <summary>2024 — 7 publications</summary>

  <div class="pub-entry">
    Sun Z-H., <strong>Zhao Y-C.</strong>, Li J-K., Liu H-Y., Cao W., Yu F., Zhang B-K., Yan M.  
    <em>Environmental factors influencing the development and spread of resistance in erythromycin-resistant Streptococcus pneumoniae.</em>  
    Environmental Geochemistry and Health, 2024.  
    <a href="https://doi.org/10.1007/s10653-024-02264-0">DOI: 10.1007/s10653-024-02264-0</a>
  </div>

  <div class="pub-entry">
    <strong>Zhao Y-C.</strong>, Sun Z-H., Li J-K., Liu H-Y., Zhang B-K., Xie X-B., Fang C-H., Sandaradura I., Peng F-H., Yan M.  
    <em>Individualized dosing parameters for tacrolimus in the presence of voriconazole: a real-world PopPK study.</em>  
    Frontiers in Pharmacology, 2024.  
    <a href="https://doi.org/10.3389/fphar.2024.1439232">DOI: 10.3389/fphar.2024.1439232</a>
  </div>

  <div class="pub-entry">
    <strong>Zhao Y-C.</strong>, Wang C-Y., Liu J-Y., Li J-K., Liu H-Y., Sun Z-H., Zhang B-K., Yan M.  
    <em>Factors affecting the effectiveness and safety of polymyxin B in the treatment of Gram-negative bacterial infections: a meta-analysis of 96 articles.</em>  
    International Journal of Antimicrobial Agents, 2024.  
    <a href="https://doi.org/10.1016/j.ijantimicag.2024.107262">DOI: 10.1016/j.ijantimicag.2024.107262</a>
  </div>

  <div class="pub-entry">
    <strong>Zhao Y-C.</strong>, Sun Z-H., Li J-K., Liu H-Y., Cai H-L., Cao W., Yu F., Zhang B-K., Yan M.  
    <em>Exploring the causes of the prevalence of vancomycin-resistant Enterococcus faecalis.</em>  
    Environmental Sciences Europe, 2024.  
    <a href="https://doi.org/10.1186/s12302-024-00923-8">DOI: 10.1186/s12302-024-00923-8</a>
  </div>

  <div class="pub-entry">
    Liang T., Lin C-Q., Ning H., Qin F., Zhang B-K., <strong>Zhao Y-C.</strong>, Cao T., Jiao S., Chen H., He Y., Cai H-L.  
    <em>Pre-treatment risk predictors of valproic acid-induced dyslipidemia in pediatric patients with epilepsy.</em>  
    Frontiers in Pharmacology, 2024.  
    <a href="https://doi.org/10.3389/fphar.2024.1349043">DOI: 10.3389/fphar.2024.1349043</a>
  </div>

  <div class="pub-entry">
    <strong>Zhao Y-C.</strong>, Sun Z-H., Xiao M-X., Li J-K., Liu H-Y., Cai H-L., Cao W., Feng Y., Zhang B-K., Yan M.  
    <em>Analyzing the correlation between quinolone-resistant Escherichia coli resistance rates and climate factors.</em>  
    Environmental Research, 2024.  
    <a href="https://doi.org/10.1016/j.envres.2023.117995">DOI: 10.1016/j.envres.2023.117995</a>
  </div>

  <div class="pub-entry">
    <strong>Zhao Y-C.</strong>, Liu H-Y., Xiao C-L., Hou J-J., Zhang B-K., Li J-K., Zhang M., Jiang Y-F., Sandaradura I., Ding X-S., Yan M.  
    <em>Enhancing voriconazole therapy in liver dysfunction.</em>  
    Frontiers in Pharmacology, 2024.  
    <a href="https://doi.org/10.3389/fphar.2023.1323755">DOI: 10.3389/fphar.2023.1323755</a>
  </div>

</details>

<!-- ==================== 2023 ==================== -->
<details>
  <summary>2023 — 4 publications</summary>

  <div class="pub-entry">
    Gao W., <strong>Zhao Y-C.</strong>, Guo L., Wang Y-K., Gong H., Zhang B-K., Yan M.  
    <em>Comparative effectiveness of glycyrrhizic acid preparations...</em>  
    Phytomedicine, 2023.  
    <a href="https://doi.org/10.1016/j.phymed.2023.154883">DOI: 10.1016/j.phymed.2023.154883</a>
  </div>

  <div class="pub-entry">
    Xia S., Gong H., <strong>Zhao Y-C.</strong>, Guo L., Wang Y-K., Ma R., Zhang B-K., Sarangdhar M., Noguchi Y., Yan M.  
    <em>Tumor Lysis Syndrome associated with monoclonal antibodies...</em>  
    Clinical Pharmacology & Therapeutics, 2023.  
    <a href="https://doi.org/10.1002/cpt.2920">DOI: 10.1002/cpt.2920</a>
  </div>

  <div class="pub-entry">
    Xia S., Gong H., Wang Y-K., Liu L., <strong>Zhao Y-C.</strong>, Guo L., Zhang B-K., Sarangdhar M., Noguchi Y., Yan M.  
    <em>Pneumocystis jirovecii pneumonia associated with immune checkpoint inhibitors.</em>  
    Frontiers in Pharmacology, 2023.  
    <a href="https://doi.org/10.3389/fphar.2023.1129730">DOI: 10.3389/fphar.2023.1129730</a>
  </div>

  <div class="pub-entry">
    Li J-K., Xiao C-L., Hou J-J., <strong>Zhao Y-C.</strong>, Gong H., Zhang B-K., Yan M.  
    <em>Clinical pharmacy undergraduate education in China.</em>  
    BMC Medical Education, 2023.  
    <a href="https://doi.org/10.1186/s12909-023-04049-y">DOI: 10.1186/s12909-023-04049-y</a>
  </div>

</details>

<!-- ==================== 2022 ==================== -->
<details>
  <summary>2022 — 6 publications</summary>

  <div class="pub-entry">
    Xia S., Gong H., <strong>Zhao Y-C.</strong>, Guo L., Wang Y-K., Zhang B-K., Sarangdhar M., Noguchi Y., Yan M.  
    <em>Association of pulmonary sepsis and immune checkpoint inhibitors.</em>  
    Cancers, 2022.  
    <a href="https://doi.org/10.3390/cancers15010240">DOI: 10.3390/cancers15010240</a>
  </div>

  <div class="pub-entry">
    <strong>Zhao Y-C.</strong>, Xiao C-L., Hou J-J., Li J-K., Zhang B-K., Xie X-B., Fang C-H., Peng F-H., Sandaradura I., Yan M.  
    <em>The effect of voriconazole on tacrolimus...</em>  
    Pharmaceutics, 2022.  
    <a href="https://doi.org/10.3390/pharmaceutics14122739">DOI: 10.3390/pharmaceutics14122739</a>
  </div>

  <div class="pub-entry">
    Xia S., <strong>Zhao Y-C.</strong>, Guo L., Gong H., Wang Y-K., Ma R., Zhang B-K., Sheng Y., Sarangdhar M., Noguchi Y., Yan M.  
    <em>Do antibody-drug conjugates increase sepsis risk?</em>  
    Frontiers in Pharmacology, 2022.  
    <a href="https://doi.org/10.3389/fphar.2022.967017">DOI: 10.3389/fphar.2022.967017</a>
  </div>

  <div class="pub-entry">
    Wang T., Miao L., Shao H., Wei X., Yan M., Zuo X., Zhang J., Hai X., Fan G., Wang W., Hu L., Zhou J., <strong>Zhao Y-C.</strong>, Xie Y., Wang J., Guo S., Jin L., Li H., Liu H., Wang Q., Chen J., Li S., Dong Y.  
    <em>Voriconazole therapeutic drug monitoring and hepatotoxicity in critically ill patients.</em>  
    IJAA, 2022.  
    <a href="https://doi.org/10.1016/j.ijantimicag.2022.106692">DOI: 10.1016/j.ijantimicag.2022.106692</a>
  </div>

  <div class="pub-entry">
    Hou J-J., Marriott D., Cattaneo D., Stocker S., Stojanova J., Alffenaar J-W., Xiao C-L., <strong>Zhao Y-C.</strong>, Gong H., Yan M.  
    <em>Therapeutic drug monitoring practices of anti-infectives: Asia-wide survey.</em>  
    Frontiers in Pharmacology, 2022.  
    <a href="https://doi.org/10.3389/fphar.2022.992354">DOI: 10.3389/fphar.2022.992354</a>
  </div>

  <div class="pub-entry">
    <strong>Zhao Y-C.</strong>, Xiao C-L., Hou J-J., Wu J-M., Xiao Y-W., Zhang B-K., Sandaradura I., Luo H., Li J-H., Yan M.  
    <em>C/MIC > 4: A potential instrument to predict the efficacy of meropenem.</em>  
    Antibiotics, 2022.  
    <a href="https://doi.org/10.3390/antibiotics11050670">DOI: 10.3390/antibiotics11050670</a>
  </div>

</details>

<!-- ==================== 2021 ==================== -->
<details>
  <summary>2021 — 7 publications</summary>

  <div class="pub-entry">
    <strong>Zhao Y-C.</strong>, Zou Y., Xiao Y-W., Wang F., Zhang B-K., Xiang D-X., Yu F., Luo H., Sandaradura I., Yan M.  
    <em>Does prolonged infusion improve meropenem efficacy?</em>  
    Infectious Diseases and Therapy, 2021.  
    <a href="https://doi.org/10.1007/s40121-021-00551-2">DOI: 10.1007/s40121-021-00551-2</a>
  </div>

  <div class="pub-entry">
    <strong>Zhao Y-C.</strong>, Zou Y., Hou J-J., Xiao C-L., Zhang B-K., Li J-K., Xiang D-X., Sandaradura I., Yan M.  
    <em>Factors affecting voriconazole trough concentration in children.</em>  
    Antibiotics, 2021.  
    <a href="https://doi.org/10.3390/antibiotics10121542">DOI: 10.3390/antibiotics10121542</a>
  </div>

  <div class="pub-entry">
    <strong>Zhao Y-C.</strong>, Xiao C-L., Hou J-J., Wu J-M., Xiao Y-W., Zhang B-K., Sandaradura I., Yan M.  
    <em>A large sample retrospective study on voriconazole concentration differences.</em>  
    Pharmaceuticals, 2021.  
    <a href="https://doi.org/10.3390/ph14121239">DOI: 10.3390/ph14121239</a>
  </div>

  <div class="pub-entry">
    <strong>Zhao Y-C.</strong>, Hou J-J., Xiao Y-W., Wang F., Zhang B-K., Zhang M., Jiang Y-F., Li J-K., Gong G-Z., Xiang D-X., Yan M.  
    <em>Predictors of voriconazole trough concentration in Child-Pugh C cirrhosis.</em>  
    Antibiotics, 2021.  
    <a href="https://doi.org/10.3390/antibiotics10091130">DOI: 10.3390/antibiotics10091130</a>
  </div>

  <div class="pub-entry">
    Tang D., Yan M., Song B-L., <strong>Zhao Y-C.</strong>, Xiao Y-W., Wang F., Liang W., Zhang B-K., Chen X-J., Zou J-J., Tian Y., Wang W-L., Jiang Y-F., Gong G-Z., Zhang M., Xiang D-X.  
    <em>Population pharmacokinetics and dosing optimization of voriconazole in liver dysfunction.</em>  
    British Journal of Clinical Pharmacology, 2021.  
    <a href="https://doi.org/10.1111/bcp.14578">DOI: 10.1111/bcp.14578</a>
  </div>

  <div class="pub-entry">
    <strong>Zhao Y-C.</strong>, Lin X-B., Zhang B-K., Xiao Y-W., Xu P., Wang F., Xiang D-X., Xie X-B., Peng F-H., Yan M.  
    <em>Predictors of adverse events and determinants of voriconazole trough concentration in kidney transplant recipients.</em>  
    Clinical and Translational Science, 2021.  
    <a href="https://doi.org/10.1111/cts.12932">DOI: 10.1111/cts.12932</a>
  </div>

</details>


<!-- ====================== LINKS ========================= -->
<h2 id="contact">Links</h2>
<ul>
  <li><a href="https://orcid.org/0000-0002-9651-4457">ORCID</a></li>
  <li><a href="https://scholar.google.com/citations?user=ZrNKcgIAAAAJ">Google Scholar</a></li>
  <li><a href="https://www.researchgate.net/profile/Yichang-Zhao">ResearchGate</a></li>
</ul>

</div>

<div class="footer">
  © 2025 Yichang Zhao
</div>

</body>
</html>
